feed,title,long_url,short_url
Benzinga,EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss,https://benzinga.com/general/biotech/24/10/41580787/eyepoints-investigational-drug-shows-early-and-sustained-improvement-than-regenerons-eylea-for-di,https://da.gd/kOT8q
